DK0492841T3 - Anti-herpes-castanosperminestere - Google Patents

Anti-herpes-castanosperminestere

Info

Publication number
DK0492841T3
DK0492841T3 DK91311275.1T DK91311275T DK0492841T3 DK 0492841 T3 DK0492841 T3 DK 0492841T3 DK 91311275 T DK91311275 T DK 91311275T DK 0492841 T3 DK0492841 T3 DK 0492841T3
Authority
DK
Denmark
Prior art keywords
herpes
castanospermine esters
castanospermine
esters
active
Prior art date
Application number
DK91311275.1T
Other languages
English (en)
Inventor
A Stanley Tyms
Paul Saiho Liu
Debra L Taylor
Prasad S Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0492841T3 publication Critical patent/DK0492841T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
DK91311275.1T 1990-12-18 1991-12-04 Anti-herpes-castanosperminestere DK0492841T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027433A GB9027433D0 (en) 1990-12-18 1990-12-18 Anti-herpes castanospermine esters

Publications (1)

Publication Number Publication Date
DK0492841T3 true DK0492841T3 (da) 1995-09-18

Family

ID=10687190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91311275.1T DK0492841T3 (da) 1990-12-18 1991-12-04 Anti-herpes-castanosperminestere

Country Status (20)

Country Link
US (1) US5385911A (da)
EP (1) EP0492841B1 (da)
JP (1) JPH04342587A (da)
KR (1) KR100192642B1 (da)
AT (1) ATE126435T1 (da)
AU (1) AU643098B2 (da)
CA (1) CA2057821A1 (da)
DE (1) DE69112192T2 (da)
DK (1) DK0492841T3 (da)
ES (1) ES2078462T3 (da)
FI (1) FI915929A (da)
GB (1) GB9027433D0 (da)
GR (1) GR3017152T3 (da)
HU (1) HU210257B (da)
IE (1) IE914400A1 (da)
IL (1) IL100233A (da)
NO (1) NO914986D0 (da)
NZ (1) NZ240976A (da)
PT (1) PT99835B (da)
ZA (1) ZA919808B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
AU2001234596A1 (en) * 2000-01-28 2001-08-07 Timothy M Block Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
GB0116643D0 (en) * 2001-07-09 2001-08-29 Virogen Ltd Antiviral compounds
US7930711B2 (en) * 2003-03-06 2011-04-19 Wegener Communications, Inc. Apparatus and method for addressing control in a network for distributed data
EP1802327A4 (en) * 2004-10-06 2009-07-15 Migenix Inc COMBINED ANTIVIRAL COMPOSITIONS WITH CASTANOSPERMIN AND METHOD OF USE
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
KR20120059447A (ko) * 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760079A (en) * 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US5017563A (en) * 1988-06-23 1991-05-21 Merrell Dow Pharmaceuticals Inc. Castanospermine esters and glycosides

Also Published As

Publication number Publication date
PT99835A (pt) 1992-12-31
IL100233A0 (en) 1992-09-06
HUT59924A (en) 1992-07-28
NZ240976A (en) 1997-03-24
FI915929A0 (fi) 1991-12-17
US5385911A (en) 1995-01-31
JPH04342587A (ja) 1992-11-30
ES2078462T3 (es) 1995-12-16
FI915929A (fi) 1992-06-19
ATE126435T1 (de) 1995-09-15
PT99835B (pt) 1999-06-30
EP0492841A1 (en) 1992-07-01
HU210257B (en) 1995-03-28
KR920011488A (ko) 1992-07-24
ZA919808B (en) 1992-09-30
GB9027433D0 (en) 1991-02-06
AU8964191A (en) 1992-06-25
DE69112192T2 (de) 1996-04-04
KR100192642B1 (ko) 1999-06-15
DE69112192D1 (de) 1995-09-21
AU643098B2 (en) 1993-11-04
GR3017152T3 (en) 1995-11-30
IE914400A1 (en) 1992-07-01
EP0492841B1 (en) 1995-08-16
IL100233A (en) 1996-03-31
NO914986D0 (no) 1991-12-17
HU913989D0 (en) 1992-03-30
CA2057821A1 (en) 1992-06-19

Similar Documents

Publication Publication Date Title
DE69310830D1 (de) CMOS-Differenzverstärker mit Gleichtaktgegenkopplung
DK0464558T3 (da) Antimigræne-alkoxypyrimidinderivater
DK0492841T3 (da) Anti-herpes-castanosperminestere
FI934203A0 (fi) Nya aktiva foereningar
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
FI910254A0 (fi) Oralt aktiva renininhibitorer.
DE69115622D1 (de) Halbleiterlaser-Verstärker
ATE107648T1 (de) 1-carbacephalosporin-antibiotika.
DE69216122D1 (de) Optisch aktive 1,3-Dioxin-4-one
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
DE69130099T2 (de) Antineoplastischer wirkstoff
FI945035A (fi) Pintasterilisointi laserkäsittelyn avulla
ITRM920063U1 (it) Il gioco del pentathlon militare
KR910016253U (ko) 코너용 캐스터를 부설한 소프트트렁크(soft trunk)
SE8604669D0 (sv) Medel for behandling av svampinfektioner i naglar
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.
IT8747543A0 (it) Dispositivo di difesa contro corpi estranei
BR7200041U (pt) Mesa de bilhar com regua de obstaculo
DK97192D0 (da) Lysindfald i gavl paa ovenlys
ITLI920008U1 (it) Gioco del totovolley
BR9004135A (pt) Jogo de mesa
IT9019775A1 (it) Dispositivo di sollevamento in presenza di ruote
SE9001307D0 (sv) Differentialservo
BR6702808U (pt) Disposicao em veiculacao de mensagens
NO903796L (no) Fremgangsmaate for fremstilling av optisk aktive epoksyder.